HR Execs on the Move

Surmodics

www.surmodics.com

 
Surmodics partners with the world`s leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. Following two recent acquisitions, the company is transforming its medical device business from being a provider of coating technologies, to offering whole-product solutions. Throughout its transformation, Surmodics` mission remains: to improve the detection and treatment of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.surmodics.com
  • 9924 West 74th Street
    Eden Prairie, MN USA 55344
  • Phone: 952.500.7000

Executives

Name Title Contact Details
John Bridgeman
Vice President of Research & Development Profile
Drew Pauly
Vice President, Product Development and Manufacturing Profile
Joseph Stich
Senior Vice President and General Manager of Human Resources and In Vitro Diagnostics Profile

Similar Companies

ValenTx

ValenTx was founded with the goal of treating some of the most pervasive health problems of our time: obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. Our approach is to create a non-surgical, endoluminal bypass device that builds on the success of established medical interventions, resulting in a highly effective and least-invasive therapy. Current treatments for these diseases include surgery, pharmacology, and medically supervised lifestyle management. The risks, costs, and in some cases poor efficacy of these treatments have hampered their broad adoption by patients, physicians, and payers alike. A truly unmet clinical need exists for a therapy that can deliver the efficacy obtained through surgery, but without the risks and costs associated with surgical intervention. The ValenTx endoluminal bypass therapy mimics the attributes of a Roux-en-Y gastric bypass and is implanted through a non-surgical, endoscopic procedure. This procedure does not require gastric stapling or permanent changes to the patient`s anatomy. The device is removable, replaceable and designed so that the physician could change the therapeutic profile, thereby optimizing the treatment towards the individual patient`s needs. ValenTx has developed a strong intellectual property portfolio, which lies at the foundation of this therapy. The company has successfully conducted a series of clinical studies demonstrating the viability, safety, and efficacy of the therapy.  

Delta Medical Systems Inc

Delta Medical Systems Inc is a Pewaukee, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Harris Medical Associates

Harris Medical Associates is a Suwanee, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Telemedicine Solutions

Telemedicine Solutions is a Hoffman Estates, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

A-1 Coast Medical Supplies

A-1 Coast Medical Supplies is a Lomita, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.